You are viewing the site in preview mode

Skip to main content

Advertisement

Table 2 Descriptive analysis of the total hospital cost and the out-of-pocket patient payments (n = 367)

From: Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore

   Total hospital cost Out-of-pocket patient payments
Variables No. (%) per episode, 2012 US$ per episode, 2012 US$
   Mean (±95% CI) p value Median Mean (±95% CI) p value Median
All subjects 367 (100%) 4,193 (±414)   2,837 2,230 (±254)   1,405
Age in years        
18-40 41 (11.2%) 5,160 (±1,791) 0.182 @ 3,456 3,031 (±730) 0.001 @ 2,468
41-60 202 (55.0%) 4,089 (±544) 2,723 2,105 (±303) 1,337
61-80 124 (33.8%) 4,044 (±624) 3,022 2,167 (±514) 1,369
Gender        
Male 139 (37.9%) 5,286 (±864) < 0.001 # 3,432 2,795 (±558) 0.006 # 1,510
Female 228 (62.1%) 3,527 (±389) 2,651 1,885 (±218) 1,334
Cancer type        
Breast CA 135 (36.8%) 2,898 (±369) < 0.001 @ 2,208 1,567 (±249) < 0.001 @ 1,167
Lymphoma 79 (21.5%) 6,560 (±1,362) 4,159 3,389 (±827) 1,972
Gastrointestinal CA 39 (10.6%) 4,145 (±859) 3,432 1,927 (±541) 1,349
Head and Neck CA 34 (9.3%) 4,565 (±1,665) 3,150 2,502 (±867) 1,486
Lung CA 31 (8.4%) 3,353 (±912) 2,314 1,861 (±947) 1,097
Sarcoma 16 (4.4%) 3,857 (±1,119) 3,479 2,331 (±701) 2,194
Genitourinary CA 15 (4.1%) 4,898 (±2,803) 2,654 2,629 (±1,498) 1,340
Gynecologic CA 13 (3.5%) 4,615 (±1,482) 3,858 2,877 (±1,317) 2,251
Other/Unknown CA 5 (1.4%) 2,707 (±1,199) 2,359 1,403 (±677) 1,364
Therapeutic GCSF        
No 48 (13.1%) 3,752 (±1,088) 0.064 # 2,392 1,544 (±384) 0.007 # 1,181
Yes 319 (86.9%) 4,267 (±450) 2,950 2,338 (±286) 1,487
Admission source        
ED 195 (53.1%) 3,721 (±503) < 0.001 @ 2,577 1,979 (±259) 0.001 @ 1,302
NCCS clinic 121 (33.0%) 3,671 (±594) 2,451 2,069 (±409) 1,377
Inpatient referral 51 (13.9%) 7,238 (±1,601) 4,436 3,570 (±1,163) 2,112
Severe sepsis        
No 315 (85.8%) 3,590 (±350) < 0.001 # 2,571 2,044 (±264) < 0.001 # 1,283
Yes 52 (14.2%) 7,879 (±1,744) 6,105 3,358 (±772) 2,073
MASCC risk        
Low 300 (81.7%) 3,790 (±412) < 0.001 # 2,571 2,162 (±283) 0.034 # 1,316
High 67 (18.3%) 5,998 (±1,249) 4,436 2,533 (±574) 1,711
Ward class        
Class A1 30 (8.2%) 5,879 (±1,875) 0.039 @ 4,086 5,245 (±1,889) < 0.001 @ 3,828
Class B1 48 (13.1%) 3,699 (±784) 2,479 3,749 (±835) 2,512
Class B2 194 (52.9%) 3,855 (±540) 2,727 1,696 (±205) 1,256
Class C 95 (25.8%) 4,602 (±923) 3,185 1,600 (±313) 1,100
  1. ED = emergency department; NCCS = National Cancer Centre Singapore; CI = confidence interval; MASCC = Multinational Association of Supportive Care in Cancer; CA = cancer; @p value from ANOVA test; #p value from two sample t-test, assumed equal variance